<SEC-DOCUMENT>0000897069-19-000240.txt : 20190624
<SEC-HEADER>0000897069-19-000240.hdr.sgml : 20190624

<ACCEPTANCE-DATETIME>20190503181257

<PRIVATE-TO-PUBLIC>

ACCESSION NUMBER:		0000897069-19-000240

CONFORMED SUBMISSION TYPE:	CORRESP

PUBLIC DOCUMENT COUNT:		3

FILED AS OF DATE:		20190503


FILER:


	COMPANY DATA:	

		COMPANY CONFORMED NAME:			DAXOR CORP

		CENTRAL INDEX KEY:			0000027367

		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]

		IRS NUMBER:				132682108

		STATE OF INCORPORATION:			NY

		FISCAL YEAR END:			1231



	FILING VALUES:

		FORM TYPE:		CORRESP



	BUSINESS ADDRESS:	

		STREET 1:		350 FIFTH AVENUE

		STREET 2:		SUITE 4740

		CITY:			NEW YORK

		STATE:			NY

		ZIP:			10118

		BUSINESS PHONE:		212-330-8500



	MAIL ADDRESS:	

		STREET 1:		350 5TH AVENUE

		STREET 2:		SUITE 4740

		CITY:			NEW YORK

		STATE:			NY

		ZIP:			10118



	FORMER COMPANY:	

		FORMER CONFORMED NAME:	IDANT CORP

		DATE OF NAME CHANGE:	19730823



</SEC-HEADER>

<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Foley & Lardner
    Document created using EDGARfilings PROfile 4.5.0.0
    Copyright 1995 - 2019 Broadridge-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div>
<table id="zf13142f112474b5380b5e7d6f57c432e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 69.43%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify"><img style="HEIGHT: 53px; WIDTH: 141px" src="image0.jpg"></div>

<div>&#160;</div>
</td>
<td style="WIDTH: 30.57%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left">ATTORNEYS AT LAW</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">777 EAST WISCONSIN AVENUE</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">MILWAUKEE, WI&#160; 53202-5306</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">414.271.2400 TEL</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">414.297.4900 FAX</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">WWW.FOLEY.COM</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">WRITER'S DIRECT LINE</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">CLIENT/MATTER NUMBER</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">103159-0101</div>
</td>
</tr>
</table>
</div>

<div>
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 24pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 234pt">May 3, 2019</div>

<table id="zdcd3c49b6df147a287f690479b013231" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="BORDER-TOP-COLOR: ; WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal; TEXT-ALIGN: justify"><u>VIA EDGAR SYSTEM</u></div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Ms. Deborah L. O'Neal</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Ms. Christina DiAngelo Fettig</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">U.S. Securities and Exchange Commission</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Division of Investment Management</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Washington, DC&#160; 20549</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">&#160;</td>
</tr>
</table>

<div><br>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify">
<table id="zf70ddab400d144a38fb0b1fe331c4207" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">Re:</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Daxor Corporation, File Nos. 333-224509 and 811-22684</u></div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Dear Ms. O'Neal and Ms. Fettig:</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; TEXT-INDENT: 36pt">On behalf of our client, Daxor Corporation ("<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Daxor</u></font>"), set forth below are Daxor's responses to comments of the Staff (the "<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Staff</u></font>") of the Securities and Exchange Commission (the "<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Commission</u></font>" or "<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>SEC</u></font>"), with respect to the above-referenced filing.&#160; The numbered items set forth below repeat (in bold italics) the comments of the Staff, and following such comments are Daxor's responses (in regular type).&#160; Attached hereto is a redline of the prospectus and statement of additional information showing changes made in response to the Staff's comments.</div>
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; TEXT-INDENT: 36pt">If the responses below are acceptable, Daxor would like to request effectiveness as soon as possible pursuant to its previously filed acceleration request.&#160; Daxor would then file a Rule 497 filing to reflect the final changes to the prospectus and the statement of additional information, as set forth herein and in the attached redline.</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">1.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Update all of the information using a recent price per share.&#160; The price currently used is $15.88 on March 6, 2019.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">As requested, Daxor has updated the information<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">.</font></font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">2.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Summary of Expenses for the Prospectus Supplement, please confirm what financial information supports the expenses set forth in the Expense Table and why it is used, and confirm the expenses are not based on stale financial information.&#160; Update the Expense Table as needed.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160; The Summary of Expenses set forth in the Expense Table is based upon the most current publicly available information &#8211; December 31, 2018.&#160; As requested, Daxor has updated the Expense Table for current information.</font></div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">&#160; </font>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic"><br>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 8pt; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: justify"><img style="HEIGHT: 53px; WIDTH: 141px" src="image0.jpg"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">U.S. Securities and Exchange Commission</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">May 3, 2019</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Page 2</div>
</div>

<div style="TEXT-ALIGN: justify">&#160;</div>

<div style="TEXT-ALIGN: justify">&#160;</div>

<div style="TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Summary of Expenses for the Prospectus Supplement, include a footnote to the Expense Table that indicates that "Other Expenses" are based on estimated amounts for the current fiscal year.<br>
</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Daxor has revised the disclosure as requested.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">4.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Summary of Expenses for the Prospectus Supplement, please revise the disclosure in footnote 5 to refer to the Form N-CSR being "filed on March 1, 2019" instead of "dated March 1, 2019."</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Daxor has revised the disclosure as requested.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">5.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Summary of Expenses for the Prospectus Supplement, there is a reference to the state and local taxes having an annualized impact to operations of approximately 0.18%.&#160; Supplementally, please tell us where that is reflected in Daxor annual financial statements.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The state and local tax is part of, and a reduction of, the overall tax benefit of $332,552 recorded in the Statement of Operations in the annual financial statements.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">6.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Example for the Prospectus Supplement, the Total Annual Expenses of 3.23% should include the 0.18% of state and local taxes.&#160; Please confirm this, and make any necessary revisions.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> As requested, Daxor has revised the Total Annual Expenses to include the state and local taxes.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">7.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Example for the Prospectus Supplement, it references estimated offering expenses of $120,650.&#160; Please confirm that this matches with the 0.2% referenced in the Expense Table, and make any necessary revisions.&#160; Please also indicate if you believe this is a reasonable estimate.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">We believe that the estimated offering expenses of $120,650 is accurate based on expenses to date, and projected expenses.&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">As requested, Daxor has updated the Expense Table for current information.</font></font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">8.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Example for the Prospectus Supplement, please update the Total Expenses Incurred to reflect any changes resulting from the prior comments.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Daxor has revised the disclosure as requested.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt">&#160;</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt">&#160;</div>

<div style="MARGIN-BOTTOM: 12pt">
<div><br>
</div>

<div style="MARGIN-BOTTOM: 12pt; MARGIN-TOP: 8pt; TEXT-ALIGN: justify"><img style="HEIGHT: 53px; WIDTH: 141px" src="image0.jpg"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">U.S. Securities and Exchange Commission</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">May 3, 2019</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Page 3</div>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt">&#160;</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">9.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Capitalization section for the Prospectus Supplement, the As Adjusted amounts need to deduct fees in addition to adding in gross proceeds.&#160; Please revise accordingly.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Daxor has revised the disclosure as requested.</font></div>

<div style="TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 10.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Capitalization section for the Prospectus Supplement, please ensure that the numbers used are consistent with the numbers used in the Expense Table, and revise accordingly.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Daxor has revised the disclosure as requested.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">11.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Use of Proceeds section for the Prospectus Supplement, the disclosure references "net proceeds to the company," but the amounts identified are actually "gross proceeds."&#160; Please revise accordingly.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Daxor has revised the disclosure as requested.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">12.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Use of Proceeds section for the Prospectus Supplement, please indicate the maturity of the interest-bearing, investment grade securities in which Daxor has invested, or will invest.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Daxor has revised the disclosure as requested.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">13.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Plan of Distribution for the Prospectus Supplement, the disclosure references the $30,000 to be reimbursed to Roth.&#160; Is this amount reflected in the Expense Table?&#160; Where?&#160; As appropriate, please make necessary revisions.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> Daxor confirms that this amount is reflected in the Expense Table, as it is included in the $120,650.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">14.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Plan of Distribution for the Prospectus Supplement, the disclosure references the $30,000 to be reimbursed to Roth, and later references that the "company has also agreed to reimburse Roth for other specified expenses."&#160; Is this second reference just referring back to the $30,000, or are there other amounts that will be reimbursed to Roth?&#160; How much, and have they been reflected in the Expense Table?&#160; Where?&#160; As appropriate, please make necessary revisions.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The only amount reimbursed to Roth is the $30,000.&#160; There are no additional amounts.&#160; Daxor <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">will revise the disclosure accordingly.</font></font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">15.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">For any comments above that apply to the Base Prospectus, please make conforming changes in the Base Prospectus.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Daxor has revised the disclosure as requested.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt">&#160;</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 12pt">
<div><br>
</div>

<div style="MARGIN-BOTTOM: 12pt; MARGIN-TOP: 8pt; TEXT-ALIGN: justify"><img style="HEIGHT: 53px; WIDTH: 141px" src="image0.jpg"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">U.S. Securities and Exchange Commission</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">May 3, 2019</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Page 4</div>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">16.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Financial Highlights in the Base Prospectus, please correct the reference in the lead in paragraph to refer to December 31, 2018 instead of 2017.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Daxor has revised the disclosure as requested.</font></div>

<div style="TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 17.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Financial Highlights in the Base Prospectus, the "Ratio of total expenses to average net assets" for 2018 is stated as 3.14%.&#160; But the Form N-CEN identifies it as 3.2%, but the monthly average net assets reported in the Form N-CEN of 12,926,348 suggest a ratio of 3.26%.&#160; Please confirm the correct ratio, and make appropriate changes in the Financial Highlights or the Form N-CEN<br>
</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The Ratio of total expenses to average net assets presented in the Form N-CSR is based on net assets using the average between the beginning and ending net assets for the year 2018. The Ratio of total expenses to average net assets presented in the N-CEN is based on average of the twelve month end net assets.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">18.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In the Base Prospectus, there is a non-diversification risk but Daxor has been operating with a diversified portfolio.&#160; Please delete this risk.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Daxor has revised the disclosure as requested.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">19.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Daxor held a shareholder meeting in 2018, but the Form N-CEN does not reflect a shareholder vote in Item B.10.&#160; Please amend the Form N-CEN to answer "Yes" to that question.&#160; Please also amend the Form N-CSR for the semi-annual period to reflect the results of the annual shareholder meeting held in June of 2018.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Daxor will amend the Form N-CEN and Form N-CSR for the semi-annual period, as requested.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">20.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">In future filings, please ensure that the auditors' consent contains language that the auditors consent to the use of their name in the report.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Response</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 72pt; DISPLAY: inline-block; TEXT-INDENT: 0px">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">In future filings, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Daxor will ensure that the consent contains this language.</font></font></div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">
<div><br>
</div>

<div style="MARGIN-BOTTOM: 12pt; MARGIN-TOP: 8pt; TEXT-ALIGN: justify"><img style="HEIGHT: 53px; WIDTH: 141px" src="image0.jpg"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">U.S. Securities and Exchange Commission</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">May 3, 2019</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Page 5</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">* * * * *</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">&#160;</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; TEXT-INDENT: 72pt">If the Staff has any questions with respect to any of the foregoing, please contact the undersigned at (414) 297-5596.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; TEXT-INDENT: 216pt">Very truly yours,</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; TEXT-INDENT: 216pt">/s/ Peter D. Fetzer</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; TEXT-INDENT: 216pt">Peter D. Fetzer</div>

<div><br>
</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Enclosures</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">cc:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Michael Feldschuh (w/o enclosures)</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; TEXT-INDENT: 36pt">Robert Michel (w/o enclosures)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: justify; TEXT-INDENT: 36pt">Daxor Corporation</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "I ;T# 2(  A$! Q$!_\0
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M+MU-C$]M'$1$!_K/D )#D\ CH@(R&KYL^'_@ZX\<>+;;28OEMU_?7D@<*8X
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MY_W_ (?_ (U5S2?@'X5T;6;'5+?4-9:>RN([B-9)HBI9&# '$8.,CU%>J44
M%?(GQB\<-XQ\8R06\L;Z3ICO!9E OSG@22;@3N#,O!SC:%X!)S]#_%7Q0OA3
MX?:C=K)(EW<H;.T,;LC"60$!@P!VE5#/V^[C()%?&E !6QX8\,:IXNUR'2-(
M@\VXDY9FX2)!U=SV49_4  D@''KZK^ OA==$\!C598Y%O-8?SGWHRE8E)6,8
M)P01N<, ,B0=0 : -#PI\%_"'AJW!N+&/6+QDVR3W\8D7HN=L9^51E<C@L,D
M;B*Z3_A!/!__ $*FA_\ @NA_^)KH** /G3XJ?!*TT72[SQ'X9:1+2V1&FTTJ
M\A5>C.CY)P.&(;H-YW8 6O"Z^_Z^//B_X4A\)?$&[M[01K9WJ"]MXTP/*5RP
M*8   #*V ,X7;SG- '!U]9_!+QM-XM\'-:ZA<23ZII;B*>20EFEC;)C<G &<
M!EZDG9DGYJ^3*[SX.Z^WA_XFZ4VZ3R+Y_L,RHBDL),!.O0"3RR2.< ]>A /L
M.O'_ -H[_DGFG_\ 85C_ /14M>P5X_\ M'?\D\T__L*Q_P#HJ6@#Y@HHHH ^
M_P"BBB@ HHHH **** /F#]H[_DH>G_\ 8*C_ /1LM>/U[!^T=_R4/3_^P5'_
M .C9:\?H U/#6FPZSXJTC2[AI%@O;V&WD:,@,%=PI(R",X/H:^B_^&<?!_\
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M "F__;: /G^O8/V<?^2AZA_V"I/_ $;%70?\,R_]3=_Y3?\ [;77_#CX/_\
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M2M__ (W0!]?T5\@?\+M^(?\ T,/_ ))6_P#\;H_X7;\0_P#H8?\ R2M__C=
M'U_17R!_PNWXA_\ 0P_^25O_ /&Z^I_"=]<:GX-T._O)/,NKK3X)IGV@;G:-
M2QP.!DD]* -BBBB@ KY0^.GA'_A'/'+:E;KBQUG=<IS]V8$>:O+$GDA\X _>
M8'W:^KZYOQYX4A\9^#K_ $9Q&)Y$WVLCX_=S+RAS@D#/RD@9VLP'6@#XDKU#
MX%^+O^$<\<KIMPV+'6=ML_'W9@3Y3<*2>24QD#]YD_=KS.>":UN);>XBDAGB
M<I)'(I5D8'!!!Y!![5'0!]M^//%</@SP=?ZRYC,\:;+6-\?O)FX08R"1GYB
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M?&5Y8:YJGVNUCT]YE3[/%'AQ)& <HH/1C^= 'N]%%% 'R!\;?^2O:[_V[_\
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M ,E#U#_L%2?^C8J /I^BBB@#Y ^-O_)7M=_[=_\ T1'7G]>@?&W_ )*]KO\
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M /F"BBB@#[_HHHH **** "BBB@#Y@_:._P"2AZ?_ -@J/_T;+7C]>P?M'?\
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M_P!N_P#Z(CKS^@#T#X)?\E>T+_MX_P#1$E?7]?('P2_Y*]H7_;Q_Z(DKZ_H
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M_P"C9:\?KV#]H[_DH>G_ /8*C_\ 1LM>/T 7-)U*;1M9L=4MUC:>RN([B-9
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M8N",9XQW'/'/J^@>#O#GA9%71='M+1PA3SE3=*REMQ#2-EV&<<$GH/05N44
M%%%% !7'_$?P+_PL#P];Z3_:/V#R;M;GS?(\W.$==N-R_P!_.<]J["B@#P#_
M (9E_P"IN_\ *;_]MH_X9E_ZF[_RF_\ VVO?Z* / /\ AF7_ *F[_P IO_VV
MC_AF7_J;O_*;_P#;:]_HH \ _P"&9?\ J;O_ "F__;:/^&9?^IN_\IO_ -MK
MW^B@#P#_ (9E_P"IN_\ *;_]MKW^BB@#R_XC_!__ (6!XAM]6_MW[!Y-HMMY
M7V3S<X=VW9WK_?QC':N0_P"&9?\ J;O_ "F__;:]_HH \ _X9E_ZF[_RF_\
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M!8LQZ!54$L>IP > 3T!H U**Y/0/B7X/\4:HNF:/K4<]XR%UB:&2(N!UV[U
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M > ?%/\ Y.%\%?\ ;C_Z5O7O]> ?%/\ Y.%\%?\ ;C_Z5O7O] !7+_$;6?[
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MN-+T34KZ!=,C1I+6U>50WFRG!*@C."./<5]%T4 ?,'_"9?'/_GUUS_P0K_\
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(H **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>COVER
<SEQUENCE>3
<FILENAME>filename3.htm
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Foley & Lardner
    Document created using EDGARfilings PROfile 4.5.0.0
    Copyright 1995 - 2019 Broadridge-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div>
<div>&#160;</div>

<div>
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>

<div>See attached pdf </div>

<div>&#160;</div>

<br>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
